Satellite Symposiums

Hear directly from industry in these popular one-hour virtual presentations. Pre-registration is not required, but encouraged to receive any pre-meeting materials from the organizing company. Note: CE Credits not offered for these Satellite Symposiums.

Friday, January 29

1:15–2:15 pm ET

Precision Imaging for Detection and Localization of Recurrent Prostate Cancer
Sponsored by Blue Earth Diagnostics, Inc.

Speaker:
Munir Ghesani, MD, FACNM, FACR; Chief of Nuclear Medicine, Mount Sinai Health, NY

Session Objectives 

  1. Understand the prevalence, incidence, and mortality rates associated with prostate cancer 
  2. Demonstrate the challenges of detecting and localizing recurrent prostate cancer using standard imaging techniques 
  3. Examine the diagnostic performance and value of PET/CT in detecting and localizing recurrent prostate cancer to inform clinical management plans 
  4. Evaluate PET/CT in clinical practice by reviewing case studies


Role of Cerianna™ (18F Fluoroestradiol) in Breast Cancer imaging 
Sponsored by Zionexa

Speakers:

  • Dr. Robert S. Bridwell, MD, MBA, Charles Town, West-Virginia
  • Dr. Hannah M. Linden, MD, Seattle Cancer Care Alliance, Washington
  •  Dr. Deepak Behera, MD, San Francisco, California

 
Dr. Bridwell reviews Cerianna’s use in clinical scenarios including some case studies. Dr Linden and Dr Behera will have a discussion on the oncologist point of view on impact of 18F Fluoroestradiol in breast cancer management. The session will conclude with a Q&A session with the speakers.

Saturday, January 30

1:15–2:15 pm ET

DetectnetTM (copper Cu 64 dotatate injection) – A Novel Agent for PET Imaging of Neuroendocrine Tumors
Sponsored by Curium

Speakers: 
Erik Mittra, MD, PhD – Chief, Nuclear Medicine & Molecular Imaging – Oregon Health & Science University (OHSU)
Adam Brown, BS, NMTCB (CNMT)(CT)(PET), RT(N) – Manager, Nuclear Medicine & Molecular Imaging – OHSU

Dr. Erik Mittra will present a summary of the clinical data on the use of Detectnet (copper Cu 64 dotatate injection) in Neuroendocrine Tumors (NETs), including case studies highlighting the clinical utility in various scenarios.  Mr. Adam Brown will be discussing the protocol and image acquisition details.  The session will conclude with a panel Q&A session, including the speakers as well as Dr. Eric Liu, a general surgeon specializing in NET patient care at the Rocky Mountain Cancer Center.




Sunday, January 31

1:15–2:15 pm ET

Expanded SPECT-CT Integration into Clinical Nuclear Medicine

Sponsored by Siemens Healthineers

Speaker:
Kathryn A. Morton, MD, Professor, Department of Radiology and Imaging Sciences. Chief, Nuclear Medicine Service
University of Utah School of Medicine

The availability of high-quality SPECT-CT has greatly expanded the diagnostic value of nuclear medicine and has provided opportunities for improved therapeutic planning. SPECT/CT can be applied to almost any nuclear medicine imaging study with a resultant improvement in definitive interpretative assessment and precise anatomic relevance. The goal of the symposium is to comprehensively profile the current and potential role of SPECT/CT for many nuclear medicine applications, including those where SPECT/CT has not played a traditional role. Join us Sunday as Dr. Morton reviews her experiences using SPECT/CT in a clinically expanded role.


Ga-68 PSMA-11: Advances in Technology, Demand & Supply | Industry Leaders’ Round-Table Discussion
Sponsored by Telix Pharmaceuticals

Speakers:

  • Chris Behrenbruch, CEO, Telix Pharmaceuticals (Moderator)
  • Delphine Chen, MD, Director of Molecular Imaging Seattle Cancer Care Alliance University of Washington
  • Jean Bonnet, Head of Strategy, Sales & Marketing, IRE
  • Uno Zetterberg, Global Sales & Product Director, Cyclotrons & PET Radiopharmacy, GE Healthcare
  • Luke Augustine, VP Business Development Nuclear Precision Health Solutions, Cardinal Health
  • Serge Lyashchenko, PharmD, MSKCC

 
This Symposium offers perspectives from Industry Leaders on recent advances in PSMA-PET Imaging and how the radiopharmaceutical industry will meet the ever increasing demand for Ga-68 PSMA-11. Topics will include insight into isotope production, distribution and supply chain, as well as the practical impact on physician practice.